For referring physicians & providers

Refer a Patient to Our Rheumatology Team

Our board-certified rheumatologists provide expert, compassionate care across five Central Florida locations — from routine rheumatology visits to IV biologic, immunosuppressant, and bone density infusions.

Send referrals straight from your EHR to our fax line: 844-815-1446.

Two female doctors in scrubs and lab coats reviewing a clipboard with smiles.

Here's how to refer your patient

Refer from your EHR

Send the referral order; it faxes directly to us at 844-815-1446. Include the clinical info below.

We review and handle the logistics

Within 2 business days, we review your referral and confirm your patient is a good fit for our care. For infusion referrals, we manage the full prior-authorization process.

Your patient calls to schedule

Once we've received the referral, the patient calls 386-561-9967 to book.

Need urgent assistance? Call us directly at 386-561-9967.

After you refer

What happens after the visit

You get a note

Full consultation note after the visit, and after each infusion cycle if applicable.

We keep you in the loop

We share updates as your patient's treatment continues, so you stay current on their care.

Documentation

What to include with a referral

The more complete the records, the faster we can get started. Infusion referrals need a bit more clinical detail for prior authorization.

Patient's full name, date of birth, and phone number
Reason for the referral
Insurance: plan name and member ID
Last office visit note, including steroids and dose
Recent labs and imaging relevant to the referral
Prior rheumatology records, if the patient has been seen before
Female doctor wearing glasses and white coat discussing medical documents with a patient in an office.
Medical professional wearing pink gloves fills a syringe from an IV drip bag while patient relaxes in the background.
Prior DMARD or biologic history: agent, dose, duration, reason for stopping
Diagnosis with ICD-10 code, if available
Specific labs: ANA, RF, anti-CCP, ANCA, anti-dsDNA, complement, CK, ESR, CRP (as applicable)
Specific infusion requested, if known (e.g., Rituximab, Reclast, Remicade)
Expertise

Conditions we treat

Questions about whether we treat a specific condition? Contact our office.

Rheumatoid Arthritis
Psoriatic Arthritis
Lupus (SLE)
Gout & Pseudogout
Osteoporosis
Scleroderma
Vasculitis
Osteoarthritis
Sjögren's Syndrome
Ankylosing Spondylitis
Inflammatory Myositis
Undifferentiated CTD
Infusion medications

If your patient needs infusion therapy

If you're unsure which applies to your patient, call us and we'll review together.

ConditionInfusion MedicationsWhen to Refer
Rheumatoid ArthritisRituximab (Rituxan) · Infliximab (Remicade) · Abatacept IV (Orencia) · Tocilizumab IV (Actemra)Inadequate response to ≥1 DMARD after 3 months; active disease with elevated CRP/ESR or worsening joint count
Psoriatic ArthritisInfliximab (Remicade)Failed ≥1 DMARD; active peripheral arthritis or enthesitis not controlled
Ankylosing Spondylitis / Axial SpAInfliximab (Remicade)Failed adequate trial (≥6 weeks each) of 2 NSAIDs; active disease with elevated BASDAI or CRP
Lupus (SLE)Belimumab IV (Benlysta) · Anifrolumab (Saphnelo) · RituximabModerate-to-severe SLE with active disease (SLEDAI >6); inadequate response to HCQ ± steroids
Lupus NephritisRituximab · Cyclophosphamide (NIH protocol)Class III or IV nephritis on biopsy; rising creatinine with active urinary sediment; Class V with nephrotic syndrome
ANCA Vasculitis (GPA / MPA / EGPA)Rituximab · Cyclophosphamide (induction)New diagnosis or relapse with organ-threatening features; positive PR3 or MPO ANCA with pulmonary, renal, or sinus involvement
Giant Cell ArteritisTocilizumab IV (Actemra)New diagnosis requiring steroid-sparing; relapsing GCA on prednisone taper
Inflammatory Myositis (PM / DM / IMNM)IVIG · RituximabFailed steroids after 4–6 weeks; CK >1000 U/L with weakness; dysphagia; ILD; antisynthetase antibodies
Scleroderma (SSc) with ILDRituximab · CyclophosphamideGround-glass or honeycombing on HRCT; DLCO or FVC <70% with decline over 12 months; rapidly progressive skin thickening
OsteoporosisZoledronic Acid (Reclast) – annualT-score ≤ -2.5; prior fragility fracture; intolerance or non-adherence to oral bisphosphonates; chronic steroid use
Questions

Questions from referring physicians

Have a question that isn't answered here? Call us at 386-561-9967.

General

Yes. We require a referral from a physician, nurse practitioner, or physician assistant for all new patients. This helps us prepare for the visit and understand what you'd like us to evaluate.

We review every referral within two business days of receiving it. Once we've confirmed your patient is a good fit, they call us at 386-561-9967 to book — appointment availability varies by location and provider.

One thing that helps: let your patient know they need to call us. A referral sitting in our queue without a call from the patient doesn't get scheduled, and that's the most common reason a referral stalls.

Complete records also move things faster. See the documentation list above for what to include.

Because your EHR is faster and more secure. A referral order sent from your system faxes straight to 844-815-1446 with the chart attached — one step for your staff, complete records on our end.

A web form would collect a name and a phone number, and we'd be calling your office for the clinical detail anyway. Rheumatology referrals need the office note, labs, and prior therapy history to be scheduled appropriately, and infusion referrals need considerably more.

If your office doesn't refer from an EHR, fax the referral to 844-815-1446 with your office note, recent labs, and the clinical detail listed above.

We accept most major plans, including Medicare and most PPO plans: Aetna, Ambetter Health, BlueCross BlueShield, Cigna, Devoted Health, FHCP Medicare, HealthFirst Health Plans, Humana, Medicare, TRICARE, UnitedHealthcare, VA Health Care, and WellCare.

Coverage can vary by plan and location. If you're unsure whether your patient's plan works, call 386-561-9967 before you send the referral — faster than finding out at scheduling. Full list: Insurance & Referrals.

Infusion-specific

Yes. Every infusion patient establishes with one of our rheumatologists before their first infusion — we don't accept infusion-only referrals.

That initial visit confirms the indication, reviews baseline labs and screening, and establishes the ongoing management plan that insurers require for authorization. It also means someone is monitoring response and tolerability over time rather than just administering the drug.

Refer as you would for any new patient, and note the infusion request on the referral so we can start the authorization process early.

It depends on the plan.

Straightforward approvals come back quickly; plans requiring step therapy, documented prior treatment failure, or peer-to-peer review take longer. We manage the whole process — authorization with the insurer, coordination with specialty pharmacy, and scheduling once approval comes through. No follow-up needed from your office.

What speeds it up most: prior DMARD or biologic history with the reason for stopping, the diagnosis with ICD-10 code, and the relevant serologies.

Refer for evaluation and let us make the call. Agent selection depends on diagnosis, prior therapy, comorbidities, screening results, and what the patient's plan will actually authorize — that's the work of the consultation.

The table above shows which agents we use by condition and the criteria that typically support a referral. If you'd like to talk through a specific case first, call 386-561-9967 — we're glad to take curbside questions from referring providers.

Yes. We don't accept infusion-only referrals, so a patient who needs Reclast establishes with one of our rheumatologists first. Refer as you would for any new patient and note that Reclast is the requested infusion.

The initial visit confirms the indication, reviews renal function and vitamin D status, rules out secondary causes of bone loss, and sets up the authorization — most of which needs to happen before a first dose regardless of who administers it.

Criteria that typically support a Reclast referral: T-score ≤ -2.5, prior fragility fracture, intolerance or non-adherence to oral bisphosphonates, or chronic steroid use.

Urgent — don't fax these and wait. Call 386-561-9967 so we can triage and schedule directly. We hold urgent slots for such cases.

If your patient has organ-threatening features — rapidly rising creatinine with active urinary sediment, pulmonary hemorrhage, mononeuritis multiplex, or vision changes in suspected GCA — send them to the emergency room rather than waiting for an outpatient appointment.

Locations

Orange City

1639 N. Volusia Ave, Suite B
Orange City, FL 32763

Kissimmee

901 E. Oak St, Suite C
Kissimmee, FL 34744

Lake Mary

795 Primera Blvd, Suite 1001
Lake Mary, FL 32746

Winter Garden

15532 W. Colonial Dr, Suite C
Winter Garden, FL 34787

Florida Arthritis & Rheumatism Inc

1400 W Oak St, Ste B and C
Kissimmee, FL 34741

Ready to refer a patient?

Send the referral from your EHR to 844-815-1446, or call if you'd like to talk through a case first.

logo